UK-based medical cannabis clinic reveals it is the first of its kind to achieve B Corp certification.
— Releaf Medical Cannabis Clinic, the UK’s leading clinic of its kind, is making headlines for becoming the first medical cannabis clinic to achieve B Corp certification. This came after extensive assessments, verified by the non-profit B Lab, confirming that Releaf meets the requirements and standards needed across social and environmental performance, transparency and accountability.
The medical cannabis sector has long struggled with credibility and consumer trust, but Releaf believes that this achievement is a step in the right direction for the company – and the industry as a whole. Achieving B Corp status is no easy feat and demonstrates that the business displays clear legal compliance and excellent public transparency while serving the wider community.
When questioned about what this certification means for the company, founder Mason Soiza said: “Achieving B Corp certification means an independent body has reviewed everything from our care model to governance, impact on patients, people and the wider community, and confirmed it meets a high standard.”
“We’re the first medical cannabis clinic to achieve this, which matters because our industry is still proving its legitimacy, so independent verification carries more weight than anything we could say about ourselves.”
Additionally, the HR Manager at Releaf, Amy Jones, stated that “Being part of B Corp means holding ourselves to the same standard we set for patient care, doing right by our people, our patients and the communities we work in. We’re proud to be part of a community of organisations that share our values.”
While medical cannabis has been legal in the United Kingdom since 2018, it is still one of the newest forms of healthcare available and faces several leading concerns. The stigma surrounding cannabis makes it hard for patients to know if they can trust genuine medical providers. Releaf hopes that its B Corp status can act as a key trust signal, showing patients that the company is legitimate and helping those in need get the medical cannabis treatment they deserve.
Releaf is expected to publish its first B Corp Impact report towards the end of July, and it will outline the company’s goals for progress across people, environment, community and governance. The report will also outline Releaf’s key targets across these sectors for 2026 and 2027.
About Releaf
Releaf is the UK’s most trusted* medical cannabis clinic, serving a wide range of patients since 2024. It has accumulated over 8,000 Trustpilot reviews and has 60 specialists prescribing medication through an advanced healthcare platform. Releaf integrates with NHS systems to offer more convenience for patients and is targeting key growth areas in other parts of the world in the coming months. According to Trustpilot (8,800 reviews) and Medical Cannabis independent industry site.
For more information, visit the website here: https://releaf.co.uk/.
Contact Info:
Name: Sophie Stephen
Email: Send Email
Organization: Releaf
Address: Releaf Dispensary Ltd, 1 King’s Avenue, London, N21 3NA
Phone: +44 7563 350859
Website: https://releaf.co.uk/
Release ID: 89198527
If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). We will respond and rectify the situation in the next 8 hours.
